Cargando…
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
Pancreatic enzyme supplements (PES) are used in chronic pancreatitis (CP) for correction of pancreatic exocrine insufficiency (PEI) as well as pain and malnutrition. The use of porcine pancreatic enzymes for the correction of exocrine insufficiency is governed by the pathophysiology of the disease a...
Autores principales: | Krishnamurty, Devi Mukkai, Rabiee, Atoosa, Jagannath, Sanjay B, Andersen, Dana K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710383/ https://www.ncbi.nlm.nih.gov/pubmed/19707261 |
Ejemplares similares
-
Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
por: Baker, Susan S
Publicado: (2008) -
Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency
por: Nakajima, Kei, et al.
Publicado: (2012) -
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis
por: Konstan, Michael W., et al.
Publicado: (2010) -
A Retrospective Real-World Evidence Evaluation of the Characteristics of Exocrine Pancreatic Insufficiency in Patients With Chronic Pancreatitis and Type 2 Diabetes Treated With Pancrelipase in the United States
por: Rosenberg, Jonathan, et al.
Publicado: (2022) -
Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis
por: Kunovský, Lumír, et al.
Publicado: (2021)